If you take Ozempic or Wegovy, will you keep losing weight or hit a plateau? Even though a plateau can be inevitable, staying on the drugs can help you maintain your weight loss.
Kristen Fischer is a journalist who has covered health news for more than a decade. Her work has appeared in outlets like Healthline, Prevention, and HealthDay.Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content.Weight loss plateaus can happen regardless of what weight loss method a person is using.
That you won’t keep dropping pounds while taking these drugs might be unwelcome news if you’re taking or considering them to help you lose a substantial amount of weight. However, doctors say they can still offer health benefits, including helping you slim down overall. According to Lampe Dominguez, the weight loss process actually increases your appetite and forces you to use less energy —this is in an attempt to regain any lost body weight or prevent additional weight loss.With medications like Ozempic and Wegovy , people are still likely to hit weight loss plateaus.
These drugs can still benefit you by reducing appetite, regulating blood sugar, and helping you feel fuller for longer. “What these drugs are doing is working in the brain to change drivers that make it very difficult for people to adhere to lifestyle interventions like diet,” said Grunvald.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Weight Loss Drugs Ozempic and Wegovy Linked to Severe Gut Problems: StudyA small percentage of users may experience severe gastrointestinal side effects.
Read more »
Ozempic, Wegovy linked to severe medical conditions including stomach problems, study findsBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
Ozempic and Wegovy linked to gastrointestinal problems in new researchGabrielle M. Etzel is the healthcare policy reporter for the Washington Examiner. Prior to joining the Washington Examiner, she served as a staff reporter at Campus Reform and as a freelance writer. After graduating from Grove City College, Etzel earned her master's in public policy and administration from Baylor University, where she conducted research on domestic sex trafficking. In her free time, Etzel enjoys being with her family in Pittsburgh, Pennsylvania.
Read more »
Wegovy and Ozempic ingredient linked to rare stomach paralysis casesA study involving 16 million people in the US found that those prescribed so-called GLP-1-agonists had an increased risk of serious gastrointestinal conditions, including stomach paralysis
Read more »
New Ozempic and Wegovy side effects come to lightThis is additional taxonomy that helps us with analytics
Read more »